Cheung Lily (CIK 1962207) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-22). Recent activity: Sell PLRX (7,534 shares), Buy PLRX (25,875 shares), Sell PLRX (3,740 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-22 | PLIANT THERAPEUTICS, INC. (PLRX) | Chief Human Resource Officer | Sell | 7,534 | $9,644 |
| 2025-01-27 | PLIANT THERAPEUTICS, INC. (PLRX) | Chief Human Resource Officer | Buy | 25,875 | $0 |
| 2025-01-22 | PLIANT THERAPEUTICS, INC. (PLRX) | Chief Human Resource Officer | Sell | 3,740 | $41,888 |
Source: SEC Form 4 filings · as of 2026-01-22